Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: Basis for therapy of cutaneous T cell lymphoma

Journal of Investigative Dermatology

Volumn 118, Issue 2, 2002, Pages 366-371

  Zaki, Mohamed H ^a   Wysocka, Maria ^a   Everetts, Suzanne E ^a   Wang, Kathy S ^b   French, Lars E ^c   Ritz, Jerome ^b   Rook, Alain H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

CTCL T cell; IL 12; IL 12 receptors; IL 2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2;

ARTICLE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; IN VITRO STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0036181424     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01646.x     Document Type: Article

References (29)

1. Antitumor and antimetastatic activity of interleukin 12 against tumors
2. Selective modulation of human natural killer cells in very prolonged infusion of low dose recombinant interleukin 2
3. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
4. Sézary syndrome T-cell clones display T-helper 2 cytokines and the accessory factor-1 (interferon-gamma receptor beta-chain)
5. Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants
6. Regulation of human cytolytic lymphocyte responses by interleukin 12
7. Altered interleukin-12 responsiveness in Th1 and Th2 cells associated with the differential activation of STAT5 and STATI
8. Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-gamma induction is associated with clinical response
9. Cell surface differentiation antigens of the malignant T cell in Sézary syndrome and mycosis fungoides
10. Interleukin-2 augments natural killer cell activity
11. CD8-positive tumor-infiltrating lymphocytes influence the long term survival of patients with mycosis fungoides
12. Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: Inhibitors of NO generation reveal the extent of rIL- 12 vaccine adjuvant effect
13. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
14. Cutaneous T cell lymphoma
15. A functional interleukin 12 receptor complex is composed of two beta-type: Cytokine receptor subunits
16. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
17. The immunopathogenesis of cutaneous T-cell lymphoma
18. The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells
19. IL-12 reverses cytokine and immune abnormalities in Sézary syndrome
20. Pathogenesis of cutaneous T-cell lymphoma: Implications for the use of recombinant cytokines and photopheresis
21. Interleukin-12 therapy of cutaneous T-cell lymphoma induced lesion regression and cytotoxic T-cell responses
22. Response of resting human peripheral blood natural killer cells to interleukin 2
23. Aberrant cytokine production by Sézary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells
24. Th2 cytokine mRNA expression in skin in cutaneous T cell lymphoma
25. Interleukin-2 enhances the response of natural killer cells to interleukin 12 through up-regulation of the interleukin-12 receptor and STAT4
26. Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation
27. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy
28. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma
29. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome